Tanya Lewis - Net Worth and Insider Trading
Tanya Lewis Net Worth
The estimated net worth of Tanya Lewis is at least $2 Million dollars as of 2024-11-10. Tanya Lewis is the Chief Dev. Op. Officer of Replimune Group Inc and owns about 135,293 shares of Replimune Group Inc (REPL) stock worth over $2 Million. Tanya Lewis is also the EVP, Chief Reg. Affairs of Karyopharm Therapeutics Inc and owns about 4,143 shares of Karyopharm Therapeutics Inc (KPTI) stock worth over $3,627. Details can be seen in Tanya Lewis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tanya Lewis has not made any transactions after 2023-06-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Tanya Lewis
Tanya Lewis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tanya Lewis owns 3 companies in total, including Karyopharm Therapeutics Inc (KPTI) , Replimune Group Inc (REPL) , and DiaMedica Therapeutics Inc (DMAC) .
Click here to see the complete history of Tanya Lewis’s form 4 insider trades.
Insider Ownership Summary of Tanya Lewis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2021-02-11 | EVP,Chief Reg.&Quality Officer |
| REPL | Replimune Group Inc | 2023-06-13 | director |
| DMAC | DiaMedica Therapeutics Inc | 2023-03-01 | director |
Tanya Lewis Latest Holdings Summary
Tanya Lewis currently owns a total of 2 stocks. Among these stocks, Tanya Lewis owns 135,293 shares of Replimune Group Inc (REPL) as of June 13, 2023, with a value of $2 Million and a weighting of 99.78%. Tanya Lewis also owns 4,143 shares of Karyopharm Therapeutics Inc (KPTI) as of February 11, 2021, with a value of $3,627 and a weighting of 0.22%.
Latest Holdings of Tanya Lewis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REPL | Replimune Group Inc | 2023-06-13 | 135,293 | 12.44 | 1,683,045 |
| KPTI | Karyopharm Therapeutics Inc | 2021-02-11 | 4,143 | 0.88 | 3,627 |
Holding Weightings of Tanya Lewis
Tanya Lewis Form 4 Trading Tracker
According to the SEC Form 4 filings, Tanya Lewis has made a total of 3 transactions in Replimune Group Inc (REPL) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Replimune Group Inc is the sale of 12,860 shares on June 13, 2023, which brought Tanya Lewis around $309,412.
According to the SEC Form 4 filings, Tanya Lewis has made a total of 2 transactions in Karyopharm Therapeutics Inc (KPTI) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Karyopharm Therapeutics Inc is the sale of 2,046 shares on February 11, 2021, which brought Tanya Lewis around $31,754.
Insider Trading History of Tanya Lewis
- 1
Tanya Lewis Trading Performance
Tanya Lewis Ownership Network
Ownership Network List of Tanya Lewis
Ownership Network Relation of Tanya Lewis
Tanya Lewis Owned Company Details
What does Karyopharm Therapeutics Inc do?
Who are the key executives at Karyopharm Therapeutics Inc?
Tanya Lewis is the EVP,Chief Reg.&Quality Officer of Karyopharm Therapeutics Inc. Other key executives at Karyopharm Therapeutics Inc include director & President and CEO Richard A. Paulson , EVP & CFO & Treasurer Michael Mason , and SVP Sales & Commercial Ops Sohanya Roshan Cheng .
Karyopharm Therapeutics Inc (KPTI) Insider Trades Summary
Over the past 18 months, Tanya Lewis made no insider transaction in Karyopharm Therapeutics Inc (KPTI). Other recent insider transactions involving Karyopharm Therapeutics Inc (KPTI) include a net sale of 165,682 shares made by Richard A. Paulson , a net sale of 55,845 shares made by Michael Mason , and a net sale of 41,559 shares made by Sohanya Roshan Cheng .
In summary, during the past 3 months, insiders sold 27,326 shares of Karyopharm Therapeutics Inc (KPTI) in total and bought 0 shares, with a net sale of 27,326 shares. During the past 18 months, 2,078,182 shares of Karyopharm Therapeutics Inc (KPTI) were sold and 41,140 shares were bought by its insiders, resulting in a net sale of 2,037,042 shares.
Karyopharm Therapeutics Inc (KPTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Karyopharm Therapeutics Inc Insider Transactions
Tanya Lewis Mailing Address
Above is the net worth, insider trading, and ownership report for Tanya Lewis. You might contact Tanya Lewis via mailing address: C/o Karyopharm Therapeutics Inc., 85 Wells Ave., Newton Ma 02459.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
